crinecerfont
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
3 FDA-registered drug labelers
Catalent Pharma Solutions, LLC
Has Healthcare Advanced Synthesis SA
Neurocrine Biosciences, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Crenessity
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Crinecerfont Capsule
04/28/2026Chemical Identity
CAS752253-39-7
PubChem CID5282340
DTXSIDDTXSID10996687
FormulaC27H28ClFN2OS
Mol. Weight483 g/mol
SMILESCC1=C(C=C(C=C1)C(CC2CC2)N(CC#C)C3=NC(=C(S3)C)C4=C(C=C(C(=C4)C)OC)Cl)F
Data Sources
52823402026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/crinecerfont/cids/JSON
Archive: data/sources/pubchem_name/crinecerfont.json
CAS 752253-39-72026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 752253-39-72026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json